lyophilized human serum can serve as an international biological serum reference material for calibration of measurements of ape A-I. However, the lyophilized material appears to be questionable for use as a reference material for all apo B methods because of significant among-method variability exhibited by certain methods. The observed high among-method variation in ape B is associated in all surveys with lower values by radial immunodiffusion (RID) and higher values by liquid immunoprecipitin (LIM) as compared with the method-weighted mean of all methods. The present survey was conducted to examine the status of the lyophilized serum preparation as a reference material for both ape A-I and B measurements, to evaluate sources of analytical bias in different immunoassay systems by assaying lyophilized preparations at different concentrations, and to evaluate the RIA method suitability for use as an interim Candidate Reference Method for ape A-I and B measurements.
Materials and Methods

IUIS Serum Reference Material for apolipoprotein.
The reference material, 1 mL of lyophilized serum, was contained in crimped, rubber-stoppered glass vials. Briefly described, a sterile, multiple filtered serum pool containing no additives was dispensed into Wheaton vials, lyophilized, and sealed in a nitrogen atmosphere. The vials were then stored at -20 #{176}C. This material was found to be stable through accelerated and long-term stability analyses previously reported (3-5). The IUTS Serum Reference Material (CDC no. 1883), designated I, was assigned consensus reference values for ape A-I and B in an especially designed study done in 1985 by a "labeling reference group" of experts at 28 laboratories. Secondary lyophili.zed reference materials. Three secondary lyophilized serum reference materials were prepared with target ape A-I and B concentrations near or greater than that of the IUIS Reference Material. These materials-designated A, B, and C-were prepared by the same procedure used for the IUIS Serum Reference Material (3). Analytical methods used by participants. Thus, laboratories using RID and LIM constituted three-fourths of the reporting laboratories.
The participant laboratories were in the following countries: Australia (5), Austria (2), Belgium Design of the study. Each collaborator was sent two sets each of seven coded vials, one set for ape A-I and the other for apo B immunoassay.
Each set consisted of two vials analyses. All reported results were used in the statistical analysis except for the following: (a) an obvious consistent dilution error made by one laboratory in three secondary reference materials for apo A-I; (b) an apparent mix-up of vials for two secondary reference materials by one laboratory for ape B; and (c) ape A-I data submitted by five laboratories, all of which used radioimmunoassay with a common antiserum reagent that gave precise but highly biased values for the IUIS Reference Material, which were inconsistent with other reported RIA results.
When we compared the mean concentrations (RIA values) reported for apo A-I for the IUIS Reference Material (specimen I) with those in previous surveys (3,4), we found that the mean value of 1.09 g/L for all RIA data submitted by 14 laboratories was lower than the previous values, which were near 1.20 g/L. Examination of the data revealed that five RLA laboratories, using the same commercially available calibrator-antiserum reagent, reported highly negatively biased values as compared with those of the other nine RIA laboratories that used their own calibration material-antiserum reagent. Also, calculation of the mean RIA value after omitting data from these five laboratories gave an ape A-I mean value of 1.20 g/L for the remaining nine RIA laboratories for the I specimen, as shown below in Table 2 . Apo A-I results for specimen I from these five laboratories are shown separately in Table 2 , but are omitted in all other statistical analyses.
To estimate components of variance and determine the relative contributions of the major sources of measurement
Results
Differences in concentration
by analytical method. The mean concentration, percent differences in mean concentration per method vs overall mean concentration (equal weights per analytical method), and among-laboratory CV are given by analytical method in Table 2 . For ape A-I, mean concentrations as measured by the five analytical methods are not significantly different for materials A, B, C, and I, but obviously differ for apo B. For apo B, both RID and ETA (rocket) show consistent negative mean differences, whereas LIM shows positive differences, and results by RIA and ELISA are similar to the mean of all methods.
Sources of analytical variation in measured concentration. Table 3 shows an analysis of variance of the reported concentrations of pools A, B, C, and I from all participants. Here, the major sources of variation were considered in a nested fashion: methods, antiserum reagent, laboratories, vials, and replicates. We conducted a separate analysis for each reference material. The CV and associated percentage of total variance is given for each source considered.
Variation ascribable to analytical methods accounts for 18-43% of the total variation for ape B, and it increases at higher concentrations. It is negligible for apo A-I. Use of different antiserum reagents (within methods) accounts for 12-22% of totalvariance for ape A-I and 7-15% of the total variance for ape B. This agrees with a previous survey (6).
The remaining variability-vials
and replicates-has CV values 5%. The total CV for ape B is about 50% larger than that for ape A-I. The various CVs are remarkably consistent when the four pools are intercompared.
The predominant source of measurement variability for both apeproteins is among-laboratory differences. This source accounts for about two-thirds of the total variability for ape A-I, independent of reference material concentration. The among-laboratory values for percentage of total variance change from about 40% to 60% with increasing ape B concentration in the reference materials. The associated among-laboratory CVs are 11-13% for ape A-I and 17-18% for apo B. These CVs are consistent when various concentrations of the four pools are compared. The same manufacturer's antiserum reagents were used by many laboratories for the same and different analytical methods. We determined the percentage difference from overall method-weighted mean concentration for each antiserum reagent source by laboratory and pool. These percent differences include those due to antisera but also due to other sources, such as laboratory and analytical method. Figure 1 depicts the averages of these differences across the four pools, shown by antibody reagent source and by method code. Each plotted point corresponds to the mean percentage difference for a single reagent-source-method-laboratory from the mean value of each pool. In some cases, a reagent was used for a single analytical method; in other cases, a reagent was used for two or more analytical methods.
The data in Figure 1 for apo A-I show differences ranging from about +30% to -30%, whereas apo B differences range from about -40% to + 60%. Mostly, the differences for the RID method with ape B are negative, and most results clearly are not antiserum-reagent-associated. There is one case of probable antiserum reagent effect: Ape A-I differences for LIM laboratories, where positive values are seen for the Orion reagent but negative values for the Immuno reagent.
Comparison of results from specific types of liquid immunoprecipitin assays. We compared concentration measurements reported for pools A, B, C, and I from L1M laboratories that we categorized into four reported types of LIM assays. Mean concentrations are shown in Table 5 . None of the comparisons of the means of these four methods on each of the four lyophilized pools were statistically n, number of laboratories.P, statistical P value from one-wayanalysisof variancetest for equal meansof four nephelometricmethods. NE, nephelometry.endpoint. NA, nephelometry, rate. TE, turbidimetry,end-point.TA, turbidimetry,rate.
ances for those laboratories that reported using the material (P <0.05).
Discussion
Since 1981, the IUIS and the CDC have collaborated in investigating and characterizing a lyophihized serum reference preparation, to determine whether it is suitable for use in international standardization of apolipoproteins A-I and B measurements. Because of the expense in the international distribution of frozen materials and instability of liquid sera in storage, it was decided to prepare a lyophilized material (3). This decision, taken in the early 1980s, was made even though it was realized that there might be problems of decreased immunological activity (i.e., apparent decreased concentration) of apolipoproteins A-I and B because of lyophilization (1) (2) (3) . In 1985 a labeling project was conducted in cooperation with 28 expert laboratories (the Expert Labeling Reference Group), the major purpose of which was to assign a tentative apo A-I and ape B concentration value to the IUIS lyophilized proposed Reference Material (5) . The Expert
Labeling
Reference Group used five techniques: ELISA (5), RIA (7), immunonephelometry (6), EIA (rocket) (5), and RID (6) . The study required participants to do immunological assays, according to a common protocol, of five dilutions-measuring the lyophilized IUIS material, another lyophilized serum material, and four fresh sera. The Group used their own or commercially acquired calibration materials and used their routine protein analysis method to determine the protein mass of the calibrator. This study indicated linearity and parallelism of slopes between fresh sera and the IUIS lyophilized serum preparation for all five analytical methods. Among-method source of error was found to be negligible for apo A-I in both lyophilized and fresh serum specimens, but for ape B it was observed to be highly significant with the lyophilized serum materials and of negligible significance with the fresh human serum ported ape A-I concentrations as measured by the four LIM methods in any of the four lyophilized materials measured. As seen in Table 2 , mean values for ape B as measured by all types of LIM were 10% to 19% higher than mean values for all methods combined. That the effects of using different manufacturers' antiserum reagents were negligible was demonstrated by the Expert Labeling Reference Group study in 1985 (6), a finding confirmed in the present survey. Analysis of variance showed that only 7-9% of the total variability in reported concentration was associated with antiserum reagent manufacturer. In our plots of mean concentration biases showing both analytical method by code and reagent manufacturer in Figures 1 and 2 , we found few caseswhere antiserum reagent appeared to be associated with bias. For ape B, among-laboratory differences and among-method differences are greater sources of variability.
In this survey, 21 laboratories reported using the IUIS material to adjust calibration curves. This indicates that the results of the survey primarily reflect the continued widespread use of calibration materials distributed by manufacturers or individual laboratories. The continuing large among-laboratory variation in bias that we observed during the surveys indicates the enduring presence of calibration problems for both ape A-I and B. In examining whether agreement among reported results of secondary reference materials can be improved by recalibration with a common reference material, independent of the assigned value, we found that expressing the three secondary lyophilized reference material concentrations relative to the IUIS Reference Material decreased the mean concentration biases for ape B, but this will not completely correct for differences observed for ape B as measured by RID and LIM, currently the most popular techniques. Improvement was found in 1985 when the IUIS Reference Material was used as a common reference point for ape A-I, but we did not find improvement in the present study.
In 1984, the CDC established an in-house RIA involving the use of fresh or rechromatographed, purified liquid ape A-I as the primary standard. Using this assay, we found a mean of 1.24 g/L (n = 95, CV = 7%) for the IUIS lyophilized Reference Material over a four-year period, during which no statistically significant trends were found. This value is in agreement with the 1986 survey value, 1.240 g/L (4), and the present 1987 survey value, 1.242 gIL, for ape A-I measurements. Accordingly, the CDC RIA assay results are used to assign a 1989 ape A-I concentration value of 1.24 g/L to the lyophilized IUIS Ape Reference Material (CDC no. 1883).
Because of the uncertainty associated with primary standards, protein analysis, and matrix effects of ape B measurements, and possible differences due to the use of wide density-cut LDL fractions (used previously by most apolipoprotein investigators) vs narrow-cut fractions (used currently), it appears inadvisable to now assign a single ape B concentration value until a scientific basis can be estab- Reference serum pools are needed to transfer values from the accuracy base through Certified Reference Materials to commercial reference materials. A common analytical dilution and transfer protocol should be utilized to transfer mass units of the accuracy base reference materials to secondary standards and quality-control materials. Having an accuracy base will help in recognizing problems originating in sample matrix, recognizing sample-derived sources of error, and establishing characteristics of valid dose-response curves. An accuracy base is essential for standardization of epidemiological studies.
In our experience, and in the surveys (3) (4) (5) , the RIA method has demonstrated, for both ape A-I and B, little difference in results for fresh, frozen, and lyophilized serum preparations; linearity and parallelism of dose-response curves with different concentrations of fresh, frozen, and lyophilized serum preparations; and agreement of results with the method-weighted mean of all immunoassays. The RIA method, thus, has been used as a CDC in-house reference method. However, choice of a Reference Method or Reference Method equivalent for ape A-I and B analysis is yet to be established.
Technical problems associated with methodology and standardization of apelipeproteins have been discussed recently (8,9). Especially important is the finding that the use of a narrow (1.030-1.050 d) LDL ultracentrifugal fraction used as the primary standard instead of the commonly used wide 1.019-1.063 d band can result in higher ape B values for serum-based reference materials and patients' specimens (10). The question arises whether total ape B in patients' specimens is better represented by ape B in highly purified LDL or by ape B in native VLDL, IDL, and LDL mixtures in serum.
Great improvements have been made in analytical performance of all immunoassays in recent years. Many different techniques, particularly ELISA, are being used for clinical purposes (11) (12) (13) (14) (15) (16) (17) . An innovative non-immunoassay method also has been reported for ape A-I (18).
In sununary, lyophilized serum-based reference materials are suitable for use with ape A-I analyses, but are of questionable suitability for ape B measurements with some methods. RID yields consistent negative biases and LIM assays yield consistent positive biases with respect to RIA for ape B. Further studies are needed on validity of proposed primary standards and serum-based reference materials,standardization of protein analysis, suitability of potential Candidate Reference Methods, sources of errors in dose-response curves, and effective methods for transferring assigned values of both frozen and lyophilized proposed international biological standards to distributed serumbased calibration and quality-control reference materials. 
